ProfileGDS5678 / 1456825_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 20% 20% 20% 20% 20% 20% 20% 20% 20% 20% 20% 20% 20% 20% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.4990420
GSM967853U87-EV human glioblastoma xenograft - Control 22.4747720
GSM967854U87-EV human glioblastoma xenograft - Control 32.4774920
GSM967855U87-EV human glioblastoma xenograft - Control 42.4191320
GSM967856U87-EV human glioblastoma xenograft - Control 52.4253220
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.5456420
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.4996420
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.4515920
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.446420
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.4653320
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.463920
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.4441720
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.4701720
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.4715820